D-1851-2019 Class III Terminated

Recalled by Macleods Pharma Usa Inc — Plainsboro, NJ

FDA drug recall D-1851-2019 was initiated by Macleods Pharma Usa Inc on Aug 21, 2019 and is designated Class III. Reason for recall: Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg The recall status is terminated (terminated Jan 28, 2021). Affected quantity: 1837 90-count bottles.

Recall details

Product Type
Drugs
Report Date
Sep 18, 2019
Initiation Date
Aug 21, 2019
Termination Date
Jan 28, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1837 90-count bottles

Product description

Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536, Manufactured by: Macleods Phamaceuticals Ltd. Baddi Himachal Pradesh, India. NDC 33342-031-10

Reason for recall

Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg

Distribution pattern

Distributed Nationwide in the USA

Code information

Lot #BPA801A, EXP 12/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1851-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1851-2019. Report a data issue: hello@regdatalab.com.